My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Emtricitabine/Tenofovir disoproxil Tillomed 200 mg/245 mg film-coated tablets



Tillomed Pharma GmbHPA22720/008/001

Main Information

Trade NameEmtricitabine/Tenofovir disoproxil Tillomed 200 mg/245 mg film-coated tablets
Active SubstancesEmtricitabine
Tenofovir disoproxil fumarate
Dosage FormFilm-coated tablet
Licence HolderTillomed Pharma GmbH
Licence NumberPA22720/008/001

Group Information

ATC CodeJ05AR Antivirals for treatment of HIV infections, combinations
J05AR03 tenofovir disoproxil and emtricitabine

Status

License statusAuthorised
Licence Issued02/10/2020
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see: Summary of Product Characteristics, section 4.2).
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable ListEmtricitabine/Tenofovir disoproxil 200 mg/245 mg Film-coated Tablets
Interchangeable List CodeIC0107-165-003
Interchangeable List DocumentPDF of Interchangeable List
« Back
Follow medicine

Print